The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients-Reference-Cited by-同舟云学术

The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients

Published:2019-06-20 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Nuzzo Tommaso,Punzo Daniela,Devoto Paola,Rosini Elena,Paciotti Silvia,Sacchi Silvia^ORCID,Li Qin,Thiolat Marie-Laure,Véga Celine,Carella Massimo,Carta Manolo,Gardoni Fabrizio,Calabresi Paolo,Pollegioni Loredano^ORCID,Bezard Erwan^ORCID,Parnetti Lucilla,Errico Francesco,Usiello Alessandro

Funder

Fondazione Cariplo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-45419-1.pdf

Reference78 articles.

1. Obeso, I. et al. Unilateral subthalamotomy in Parkinson’s disease: Cognitive, psychiatric and neuroimaging changes. Cortex 94, 39–48, https://doi.org/10.1016/j.cortex.2017.06.006 (2017).

2. Poewe, W. et al. Parkinson disease. Nat Rev Dis Primers 3, 17013, https://doi.org/10.1038/nrdp.2017.13 (2017).

3. LeWitt, P. A. Levodopa therapy for Parkinson’s disease: Pharmacokinetics and pharmacodynamics. Mov Disord 30, 64–72, https://doi.org/10.1002/mds.26082 (2015).